Mkts

Cardiff Oncology, Inc.

NASDAQ: CRDF
$0.84-0.01 (-0.87%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
0.810.88
52-week range
0.713.31
Today
Open0.84
Previous close0.84
Volume—
Valuation
Market cap67.11M
P/E ratio—
EPS (TTM)-0.59
Income & risk
Dividend / yield—
Beta1.52
Avg volume1.15M
Discussion

CRDF News

Stories mentioning CRDF from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue41.00243.00120.00121.00109.00150.00165.00163.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin6,1262,9953,8973,3184,0143,0113,1263,215
Total Operating Expenses12,8918,07012,09414,89814,49112,72212,76612,708
Operating Income (Loss)(12,850)(7,827)(11,974)(14,777)(14,382)(12,572)(12,601)(12,545)
Interest Income506.00612.00716.00835.00941.00787.00741.00805.00
Interest Expense
Other Expense(1.00)(1.00)0.00(1.00)7.00(2.00)5.00(38.00)
Pretax Income
Tax Provision
Net Income (Loss)(12,345)(7,216)(11,258)(13,943)(13,434)(11,787)(11,855)(11,778)
Earnings Per Share (Basic)(0.18)(0.11)(0.17)(0.21)(0.20)(0.25)(0.25)(0.26)
Earnings Per Share (Diluted)(0.18)(0.11)(0.17)(0.21)(0.20)(0.25)(0.25)(0.26)
Weighted Average Shares Outstanding (Basic)68,35066,84166,87966,52666,52447,65046,86544,825
Weighted Average Shares Outstanding (Diluted)68,35066,84166,87966,52666,52447,65046,86544,825

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRDF

Cardiff Oncology, Inc. (NASDAQ: CRDF) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRDF. It last traded at $0.8400 (Nov 18, 2026, 4:00 PM ET), down 0.9% on the day. That gives Cardiff Oncology a market capitalisation of $67.1M.

Over the past 52 weeks CRDF has traded between $0.7100 and $3.31.

Revenue for the quarter ended Mar 31, 2026 was $41.0K; a net loss of $12.3M. Revenue was down 62.4% from $109.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$41.0K-$12.3M-30109.8%
Dec 31, 2025$243.0K-$7.2M-2969.5%
Sep 30, 2025$120.0K-$11.3M-9381.7%
Jun 30, 2025$121.0K-$13.9M-11523.1%

From Cardiff Oncology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…